Screener
AbCellera Biologics Inc. ABCL Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001703057-26-000046
| Line item | December 31, 2025 | June 30, 2026 |
|---|---|---|
| Intangible assets, net | 38,381 | 36,530 |
| Goodwill | 47,806 | 47,806 |
| Investments in equity accounted investees | 62,580 | 65,229 |
| Other long-term assets | 51,948 | 62,103 |
| Total long-term assets | 628,718 | 628,345 |
| Total assets | $1,356,950 | $1,307,575 |
| Liabilities and shareholders' equity | ||
| Current liabilities: |
Item 1. Financial Statements (Unaudited)
FAQ
- What is AbCellera Biologics Inc.'s other non-current assets?
- AbCellera Biologics Inc. (ABCL) reported other non-current assets of $62.1M in Q2 2026.
- How has AbCellera Biologics Inc.'s other non-current assets changed year-over-year?
- AbCellera Biologics Inc.'s other non-current assets increased by 8.1% year-over-year, from $57.45M to $62.1M.
- What is the long-term trend for AbCellera Biologics Inc.'s other non-current assets?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s other non-current assets has grown at a 44.0% compound annual growth rate (CAGR), from $8.39M to $51.95M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about AbCellera Biologics Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude